Please select the option that best describes you:
Topics:
Rheumatology • Interstitial lung disease • Antiphospholipid Syndrome • General Rheumatology • CTD-ILD • Pulmonary • APS
In a patient with known APS (triple positive) and interstitial lung disease (NSIP), how do you distinguish APS associated lung involvement from connective tissue disease related ILD?
Patient has a +ANA but no other clear clinical features of SLE or another defined connective tissue disease.